Comparison of the stocks of the 20 companies that are listed on the SMI (Swiss Market Index). The graphs and histograms developed for this analysis show the performance indicators and features of each company and highlight potential opportunities and risk. The stock comparison tool is intended to obtain insights into price changes, volatility, relative volume, technical indicators (RSI, MFI), distance to minimum and relative position which are useful for a trader to base its decisions on. The visual representation of these features provides an insight into current performance, risks and opportunities related to trading or investing. The direct comparisons are expanded with a peer group analysis to obtain an overall view of the price performance, trading volume and volatility of the SMI in relation to all other stocks.
For several traded companies, a deeper analysis of their stock performance such as their behavior over time and their technical indicators is available. For the SMI the selection stocks are ABB, Nestle, Novartis, Richemont, Roche, Sika and UBS Group.
Chart sections comparing and analysing the SMI
• Key features
• Index performance
• Performance insights
• Trading opportunities
• Understanding risk
• Peer comparison
Key Features · The main indicator values of individual SMI shares used in the stock comparison [guide]
Company | Close | Price-1m | Price-3m | Volume-1m | Volatility-1m | Volatility-3m | RSI-14 | MFI | TradeValue-1m |
---|---|---|---|---|---|---|---|---|---|
ABB | 47.24 | -3.5 | -4.6 | 124.7 | 1.9 | 2.9 | 42.8 | 41.1 | 4,069,542,182.00 |
Alcon | 84.70 | 5.7 | 9.8 | 140.7 | 2.8 | 3.3 | 81.3 | 80.3 | 2,150,690,394.00 |
Geberit | 558.40 | 7.1 | 8.0 | 161.2 | 4.0 | 5.6 | 18.3 | 24.0 | 1,720,503,876.00 |
Givaudan | 3,832.00 | -3.7 | -3.8 | 120.0 | 2.4 | 2.0 | 26.4 | 20.0 | 1,894,943,779.00 |
Holcim | 96.88 | 3.1 | 10.8 | 133.0 | 2.2 | 5.5 | 45.8 | 47.2 | 3,625,541,660.00 |
Kuehne+Nagel | 208.20 | -4.0 | 0.3 | 130.3 | 2.1 | 2.2 | 48.1 | 48.5 | 1,265,166,128.00 |
Logitech | 77.72 | -16.4 | 3.5 | 97.4 | 5.9 | 7.2 | 40.2 | 46.7 | 1,183,849,179.00 |
Lonza Group | 562.40 | -2.7 | 4.5 | 96.0 | 2.3 | 3.8 | 74.0 | 62.5 | 2,115,630,344.00 |
Nestle | 90.54 | 1.7 | 21.7 | 112.1 | 1.3 | 7.9 | 57.6 | 58.0 | 10,264,867,445.00 |
Novartis | 98.66 | -2.0 | 11.1 | 136.4 | 1.5 | 4.0 | 60.0 | 66.3 | 10,612,914,907.00 |
Partners Group Holding | 1,295.50 | -2.2 | 5.1 | 128.6 | 1.9 | 3.7 | 57.1 | 45.7 | 2,072,392,206.00 |
Richemont | 158.00 | -11.9 | 15.0 | 125.0 | 5.8 | 9.0 | 36.4 | 40.3 | 4,979,514,178.00 |
Roche | 296.60 | -0.9 | 17.0 | 113.2 | 1.5 | 5.7 | 41.0 | 55.1 | 10,169,836,684.00 |
Sika | 218.80 | -4.4 | 1.0 | 155.2 | 2.1 | 3.1 | 29.7 | 42.2 | 2,660,745,327.00 |
Sonova Holding | 263.00 | -10.0 | -11.3 | 111.5 | 3.7 | 5.8 | 26.0 | 38.9 | 957,834,492.00 |
Swiss Life Holding | 808.60 | 4.2 | 15.9 | 121.0 | 1.5 | 4.2 | 65.7 | 52.3 | 1,548,092,482.00 |
Swiss Re | 151.35 | 8.7 | 15.0 | 114.6 | 2.1 | 4.2 | 77.3 | 50.7 | 3,389,597,064.00 |
Swisscom | 514.50 | 1.7 | 2.3 | 136.0 | 1.8 | 2.1 | 33.7 | 56.9 | 1,595,353,858.00 |
UBS Group | 27.95 | -7.1 | 1.1 | 152.6 | 3.2 | 4.1 | 48.8 | 41.0 | 6,557,855,223.00 |
Zurich Insurance Group | 621.40 | 5.5 | 15.2 | 106.4 | 1.8 | 5.0 | 91.5 | 65.3 | 4,205,390,218.00 |
Index Performance · Recent behaviour of equities based trading activity and results [guide]
Performance Insights · Combine features to analyse their relationship [guide]
Trading Opportunities · Guidance with technical indicators to identify SMI shares of interest to potentially buy or sell [guide]
Understanding Risk · Recent fluctuations or movements that indicate possible change in share price [guide]
Peer Comparison · Compare the performance of companies listed on the SMI to all available on StoCoTo [guide]
Useful resources
Stocoto.com provides a tool to obtain more insights into stock performance, opportunity and risk. Stocoto.com does not give advice. It is advised to use additional resources to make informed decisions. It is the decision of the user to buy or sell a stock. The price of a stock can increase or decrease.